| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |